AmerisourceBergen Corp. (NYSE:ABC) Director Henry Wadsworth Mcgee III sold 10,585 shares of the stock in a transaction that occurred on Thursday, July 11th. The stock was sold at an average price of $91.97, for a total value of $973,502.45. Following the completion of the transaction, the director now owns 24,510 shares of the company’s stock, valued at $2,254,184.70. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
ABC opened at $89.85 on Friday. AmerisourceBergen Corp. has a 52 week low of $69.36 and a 52 week high of $94.85. The stock’s fifty day moving average price is $84.29. The stock has a market capitalization of $18.88 billion, a price-to-earnings ratio of 13.84, a P/E/G ratio of 1.75 and a beta of 0.95. The company has a debt-to-equity ratio of 1.43, a quick ratio of 0.56 and a current ratio of 0.95.
AmerisourceBergen (NYSE:ABC) last released its quarterly earnings results on Thursday, May 2nd. The company reported $2.11 EPS for the quarter, topping the consensus estimate of $1.96 by $0.15. AmerisourceBergen had a return on equity of 46.24% and a net margin of 0.53%. The business had revenue of $43.32 billion during the quarter, compared to analyst estimates of $43.44 billion. During the same period last year, the business posted $1.94 earnings per share. The company’s quarterly revenue was up 5.6% on a year-over-year basis. Research analysts expect that AmerisourceBergen Corp. will post 6.85 earnings per share for the current year.
Several research analysts recently weighed in on the company. Zacks Investment Research upgraded Eutelsat Communications from a “hold” rating to a “strong-buy” rating and set a $21.00 price objective for the company in a research report on Wednesday, June 12th. Bank of America set a $25.00 price objective on Bed Bath & Beyond and gave the stock a “buy” rating in a research report on Wednesday, April 10th. Argus lowered their price objective on AmerisourceBergen from $115.00 to $100.00 and set a “buy” rating for the company in a research report on Monday, June 3rd. TheStreet upgraded TerraForm Power from a “c” rating to a “b-” rating in a research report on Tuesday, March 19th. Finally, Guggenheim increased their price objective on Intuit from $260.00 to $310.00 in a research report on Thursday, April 11th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $88.33.
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. UNIVEST FINANCIAL Corp raised its stake in shares of AmerisourceBergen by 2.3% in the second quarter. UNIVEST FINANCIAL Corp now owns 43,705 shares of the company’s stock valued at $3,726,000 after acquiring an additional 978 shares in the last quarter. CENTRAL TRUST Co raised its stake in shares of AmerisourceBergen by 55.4% in the second quarter. CENTRAL TRUST Co now owns 3,702 shares of the company’s stock valued at $335,000 after acquiring an additional 1,319 shares in the last quarter. Ridgewood Investments LLC raised its stake in shares of AmerisourceBergen by 38.7% in the second quarter. Ridgewood Investments LLC now owns 5,972 shares of the company’s stock valued at $509,000 after acquiring an additional 1,667 shares in the last quarter. Exane Derivatives raised its stake in shares of AmerisourceBergen by 39,791.1% in the second quarter. Exane Derivatives now owns 40,290 shares of the company’s stock valued at $3,434,000 after acquiring an additional 40,189 shares in the last quarter. Finally, Rothschild Investment Corp IL raised its stake in shares of AmerisourceBergen by 1.1% in the second quarter. Rothschild Investment Corp IL now owns 12,345 shares of the company’s stock valued at $1,053,000 after acquiring an additional 140 shares in the last quarter. Institutional investors and hedge funds own 66.52% of the company’s stock.
AmerisourceBergen Company Profile
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.
Further Reading: Are all No-Load Funds Equal?
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.